BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 17413034)

  • 21. Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity.
    Li R; Wang WQ; Zhang H; Yang X; Fan Q; Christopher TA; Lopez BL; Tao L; Goldstein BJ; Gao F; Ma XL
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1703-8. PubMed ID: 17895290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury.
    Lefer AM; Ma XL; Weyrich A; Lefer DJ
    Agents Actions Suppl; 1993; 41():127-35. PubMed ID: 8317336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reperfusion liver injury induces down-regulation of eNOS and up-regulation of iNOS in lung tissues.
    Lin HI; Chou SJ; Wang D; Feng NH; Feng E; Chen CF
    Transplant Proc; 2006 Sep; 38(7):2203-6. PubMed ID: 16980043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress.
    Osto E; Matter CM; Kouroedov A; Malinski T; Bachschmid M; Camici GG; Kilic U; Stallmach T; Boren J; Iliceto S; Lüscher TF; Cosentino F
    Circulation; 2008 Nov; 118(20):2073-80. PubMed ID: 18955669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic/endothelial nitric oxide synthase knockout mice.
    Quaschning T; Voss F; Relle K; Kalk P; Vignon-Zellweger N; Pfab T; Bauer C; Theilig F; Bachmann S; Kraemer-Guth A; Wanner C; Theuring F; Galle J; Hocher B
    J Am Soc Nephrol; 2007 Mar; 18(3):730-40. PubMed ID: 17287431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TNF-alpha modulates arteriolar reactivity secondary to a change in intimal permeability.
    Matsuki T; Duling BR
    Microcirculation; 2000 Dec; 7(6 Pt 1):411-8. PubMed ID: 11142338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular arginase contributes to arteriolar endothelial dysfunction in a rat model of hemorrhagic shock.
    Johnson RA; Durante W; Craig T; Peyton KJ; Myers JG; Stewart RM; Johnson FK
    J Trauma; 2010 Aug; 69(2):384-91. PubMed ID: 20699748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial dysfunction in rat mesenteric artery after regional cardiac ischaemia-reperfusion.
    Zhao M; He X; Wier WG; Zhang HL; Zhao M; Yu XJ; Zang WJ
    Exp Physiol; 2012 Jan; 97(1):70-9. PubMed ID: 21948192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production.
    Mihov D; Bogdanov N; Grenacher B; Gassmann M; Zünd G; Bogdanova A; Tavakoli R
    Eur J Cardiothorac Surg; 2009 May; 35(5):839-46; discussion 846. PubMed ID: 19237290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure.
    Vercauteren M; Remy E; Devaux C; Dautreaux B; Henry JP; Bauer F; Mulder P; Hooft van Huijsduijnen R; Bombrun A; Thuillez C; Richard V
    Circulation; 2006 Dec; 114(23):2498-507. PubMed ID: 17101854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
    J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial arginase II constrains endothelial NOS-3 activity.
    Lim HK; Lim HK; Ryoo S; Benjo A; Shuleri K; Miriel V; Baraban E; Camara A; Soucy K; Nyhan D; Shoukas A; Berkowitz DE
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3317-24. PubMed ID: 17827260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo.
    Schäfer A; Alp NJ; Cai S; Lygate CA; Neubauer S; Eigenthaler M; Bauersachs J; Channon KM
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1720-6. PubMed ID: 15242858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletion of neuronal NOS prevents impaired vasodilation in septic mouse skeletal muscle.
    Lidington D; Li F; Tyml K
    Cardiovasc Res; 2007 Apr; 74(1):151-8. PubMed ID: 17258180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphatic thoracic duct ligation modulates the serum levels of IL-1beta and IL-10 after intestinal ischemia/reperfusion in rats with the involvement of tumor necrosis factor alpha and nitric oxide.
    Cavriani G; Domingos HV; Oliveira-Filho RM; Sudo-Hayashi LS; Vargaftig BB; de Lima WT
    Shock; 2007 Feb; 27(2):209-13. PubMed ID: 17224798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide stimulatory and endothelial protective effects of idoxifene, a selective estrogen receptor modulator, in the splanchnic artery of the ovariectomized rat.
    Ma XL; Gao F; Yao CL; Chen J; Lopez BL; Christopher TA; Disa J; Gu JL; Ohlstein EH; Yue TL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):786-92. PubMed ID: 11046119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy.
    Schrader LI; Kinzenbaw DA; Johnson AW; Faraci FM; Didion SP
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2576-81. PubMed ID: 17962626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease.
    Tatematsu S; Wakino S; Kanda T; Homma K; Yoshioka K; Hasegawa K; Sugano N; Kimoto M; Saruta T; Hayashi K
    J Am Soc Nephrol; 2007 Mar; 18(3):741-9. PubMed ID: 17267746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Liu YN; Zhou ZM; Chen P
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus.
    Shemyakin A; Kövamees O; Rafnsson A; Böhm F; Svenarud P; Settergren M; Jung C; Pernow J
    Circulation; 2012 Dec; 126(25):2943-50. PubMed ID: 23183942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.